What is Eribulin Mesilate and how does it work in the body?
Eribulin Mesilate is a chemotherapy drug used to treat certain types of cancers, including breast cancer and soft tissue sarcomas. It works by disrupting the growth of cancer cells, ultimately leading to their death.

Who is a suitable candidate for Eribulin Mesilate treatment?
Eribulin Mesilate is typically prescribed for patients with advanced or metastatic cancers who have already received other forms of chemotherapy. Your healthcare provider will determine if you are a suitable candidate for Eribulin Mesilate based on your specific medical history and cancer type.

What are the common side effects associated with Eribulin Mesilate?
Some common side effects of Eribulin Mesilate include fatigue, nausea, hair loss, decreased appetite, and constipation. These side effects can vary in severity from person to person, and it is important to discuss any concerns with your healthcare provider.

How is Eribulin Mesilate administered and how often will I need to receive treatment?
Eribulin Mesilate is typically administered intravenously, meaning it is given through a vein in your arm or hand. The frequency of treatment will depend on your specific cancer type and stage, as well as how well you tolerate the medication. Your healthcare provider will create a treatment plan tailored to your individual needs.

What should I do if I experience severe side effects while taking Eribulin Mesilate?
If you experience severe side effects or any unusual symptoms while taking Eribulin Mesilate, it is crucial to contact your healthcare provider immediately. They can provide guidance on managing side effects and may adjust your treatment plan if necessary.